cancer


Investors Opening Eyes to Opportunity in Israel Cannabis, Including Exclusive CEO Video Interview Part #2

December 23rd, 2019 - Ryan Allway

There is no country on Earth that has a history steeped in cannabis research like that of Israel. Furthermore, there is no government that is more supportive of medical marijuana research than Israel. Yet, the small country has by and large gone overlooked for what it has to offer as an investment opportunity. That is […]

Europe: The Cannabis Industry’s Next Emerging Market

September 19th, 2019 - Ryan Allway

The global cannabis industry is projected to reach $66.3 billion by 2025, according to Grand View Research, representing a 23.9 percent compound annual growth rate. While North America has become a market leader, European markets are quickly catching up with their own liberalized laws. The market for health and wellness products, such as cannabidiol (CBD) […]

Synthetic Cannabinoids: The New Age of Medical Marijuana

July 22nd, 2019 - Ryan Allway

Believe it or not, the world’s first blockbuster drug is still one of the most commonly used today. Acetylsalicylic acid, better known as Aspirin®, is a synthetic derivative of the natural substance salicylic acid, an extract from the bark of the white willow tree. Any company would like to invent a drug that enjoys 100+ […]

Israel: A Cannabis Pioneer Then…and Now

July 10th, 2019 - Ash Stringer

When it comes to cannabis, Israel proves that big things can come in small packages. While recreational marijuana remains illegal in Israel, a country about the size of New Hampshire, the government has been proactive in supporting cannabis research for decades while other countries stagnated in the darkness of cannabis prohibition.  In the U.S., cannabis […]

Jushi Merges Finance and Operational Expertise to Target U.S. Market (Plus Exclusive CFN Interview)

June 28th, 2019 - Ryan Allway

The Canadian cannabis market is maturing, and savvy investors are looking south for new opportunities. While there are a growing number of multi-state operators, there are only a handful that combine financial and operational expertise — and even fewer with management teams that have a meaningful stake in the business. Investors may want to look […]

Cannabis Holding Companies Offer Diversification & Growth Potential

June 26th, 2019 - Ryan Allway

Suppose that you want to invest in a portfolio of cannabis companies. You could purchase an exchange-traded fund (ETF) or build your own portfolio by carefully selecting individual publicly-traded companies. While these are good approaches, you’re limited to publicly-traded companies and the valuations they’re assigned by the market. You can’t access privately-held companies at low […]

7 Minutes with Matt Willer and a Little Cannabis Alliteration

June 18th, 2019 - Ash Stringer

  Marcus Lemonis, the iconic entrepreneurial Profit, is famously known for building successful businesses under the mantra of “people, process and product.” If there is a company employing the “3 P’s” recipe in the cannabis space, it’s STWC Holdings Inc. (OTCQB: STWC), or Strainwise Consulting as it is often called, a company steeped with experience […]

FSD Pharma Brings in World-Renowned Experts to Build Bioscience Division

June 4th, 2019 - Ryan Allway

The cannabis industry is quickly maturing from home grows and bongs to industrial-scale cultivation and innovative new product formats. At the core of this transformation, science is helping transform medical cannabis into cutting-edge pharmaceuticals and recreational cannabis into compelling alternatives to tobacco and alcohol. Companies that recognize the role of science are best positioned to […]

Pascal Biosciences Announces Formation of Clinical Advisory Board

May 8th, 2019 - Ryan Allway

Preeminent Neuro-Oncology Experts to Guide PAS-403 Development Efforts VANCOUVER, British Columbia and SEATTLE, May 08, 2019 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS)(“Pascal” or the “Company”), a drug discovery and development company, today announced it has formed a clinical advisory board (“CAB”) of preeminent neuro-oncology experts to guide its PAS-403 therapeutic program. PAS-403 is Pascal’s clinical […]

TransCanna Acquires Massive Vertically Integrated Cannabis Facility in California

April 24th, 2019 - Ryan Allway

California’s cannabis industry is projected to generate more than $6.5 billion in annual revenue by 2020, according to New Frontier Data and Arcview Market Research, which represents a 23.1% compound annual growth rate. Many companies are racing to build their production footprint, introduce new brands, expand distribution, and open new dispensaries, but few have reached […]

Why Women, the Fastest Growing Consumers of Cannabis, are the Demographic to Watch

April 17th, 2019 - Joy Crosby

Although women control around $30 trillion in annual spending, the majority of companies often ignore this powerhouse of a demographic. Millennial women in particular tend to enjoy an above-average household income, and have been estimated to represent a $170 billion dollar market. Despite being a newer industry with a keen ability to identify exciting new […]

Why Branding Matters in the Cannabis Industry

April 16th, 2019 - Ryan Allway

The global cannabis industry is projected to reach $146.4 billion by 2025, according to Grand View Research, representing a blistering 34.6 percent compound annual growth rate. While the industry is known for strain names, like OG Kush and Girl Scout Cookies, there aren’t established marquee brands like those found in tobacco or pharmaceutical industries—which has […]

Harvest One Ensures Cannabis Supply with Greenbelt Acquisition

April 9th, 2019 - Ryan Allway

Vertical integration has become kind of a buzzword in the cannabis industry over the last few years. Many companies claim it as a goal, with the intent of controlling the whole supply chain for their products from seed-to-sale. Getting to that level of control can prove difficult, however, as the resources, equipment, and expertise required […]

American Cannabis Market Fueled By Positive Legislation

April 8th, 2019 - Ryan Allway

Cannabis may be illegal on a federal level across the United States, but that hasn’t stopped a multi-billion dollar industry from emerging on the state level. While some investors have avoided the country’s cannabis market due to the federal risk, new cannabis legislation in the House and Senate could dramatically reshape the industry’s risk profile. […]

Exclusive Interview: Gabriella’s Kitchen Cements The Foundation Upon Which to Build Its California Cannabis House of Brands

April 5th, 2019 - Ryan Allway

The time for promise and a good story is over in the cannabis industry. Potential production has been replaced with actual sales, and companies are distinguishing themselves with real revenue growth and clear paths to profitability. There is certainly much to be written in the ever-evolving story of cannabis, but the best companies are executing […]

FSD Pharma Promotes New Leadership & Advances Projects

April 1st, 2019 - Ryan Allway

Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of recreational cannabis last year and the upcoming legalization of oils, concentrates and edibles. Investors have many opportunities in the space, but few companies offer both a massive production footprint and strategic investments in new […]

Interview with Gabriella’s Kitchen CEO Margot Micallef

March 20th, 2019 - Ryan Allway

CFN Media recently sat down with Gabriella’s Kitchen (CSE: GABY) (OTCBB:GABLF) CEO Margot Micallef to discuss the global implications of Gaby’s innovative products. New beginnings Gabriella’s Kitchen is a cannabis wellness company founded in health and nutrition. Spurred by a dire cancer prognosis, sisters Gabriella and Margot sought a healthier lifestyle that might prolong Gabriella’s life. […]

CFN Media Exclusive Interview with Creso Pharma COO John Griese

March 11th, 2019 - Ryan Allway

The global cannabis industry is projected to hit $150 billion by 2025, according to Grand View Research, driven by the legalization of recreational and medical cannabis across a growing number of jurisdictions. Creso Pharma is positioned well to generate revenues from around the world. Creso Pharma Inc.(ASX: CPH) recently received a Canadian license to cultivate for […]

Supreme Cannabis Strengthens Board of Directors with the Appointment of Kenneth R. McKinnon

March 7th, 2019 - Ryan Allway

TORONTO, March 7, 2019 /CNW/ – The Supreme Cannabis Company, Inc.(“Supreme Cannabis” or the “Company”) (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), today announced the strengthening of its board of directors (the “Board”) with the appointment of a new independent director, Kenneth R. McKinnon, Q.C. As an experienced corporate executive and director, Mr. McKinnon brings substantial financial […]

Emerald Health Therapeutics’ Licensed Endo Product Wins Taste For Life’s 2019 Essentials Supplement Award in the U.S.

March 7th, 2019 - Ryan Allway

Novel Emerald endocannabinoid-supporting products well-positioned to develop brand presence and market demand among both cannabis and non-cannabis users SAN DIEGO, March 07, 2019 (GLOBE NEWSWIRE) — Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV:EMH; OTCQX:EMHTF)  today announced that its joint venture partner’s, (Emerald Health Bioceuticals or “EHB”), Endo Bliss, won Taste For Life’s 2019 Essentials Supplement Award, […]

FSD Pharma’s Investments Provide Unique Diversification

March 5th, 2019 - Ryan Allway

The Canadian cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of adult-use cannabis last year. With the upcoming legalization of edibles this fall, the market could significantly expand its addressable market beyond consumers willing to smoke cannabis. These dynamics could help lift the value […]

MedMen Reports Second Quarter Fiscal Year 2019 Financial Results

February 28th, 2019 - Ryan Allway

LOS ANGELES MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF) (FSE: A2JM6N) today released its consolidated financial results for the second quarter of fiscal 2019. All financial information for the 13-week period ended December 29, 2018 is reported in U.S. dollars, unless otherwise indicated. Management Commentary “Our strong second quarter results support […]

Creso Pharma Secures Canadian License to Cultivate in Nova Scotia

February 27th, 2019 - Ryan Allway

Creso Pharma Inc.(ASX: CPH) is a commercial-stage company that operates in multiple parts of the burgeoning cannabis industry. With an existing line of health and wellness products, the company is actively generating revenue across European markets. The company’s recently granted license to cultivate in Nova Scotia provides additional exposure to Canada’s recreational and medical markets and […]

Michigan: A Lucrative Cannabis Market with Tight Regulations

February 27th, 2019 - Ryan Allway

Several states have legalized recreational cannabis over the past few years, but almost all of these states have been progressive coastal states. Last November, Michigan became the first midwestern state to legalize recreational cannabis. The Marijuana Business Factbook 2018 projects that Michigan could become one of the country’s largest recreational markets, generating $1.4 billion to […]

Halo Labs Signs Bulk Biomass Procurement and Bulk Extract Supply Agreement with Cannus Partners in California

February 26th, 2019 - Ryan Allway

CATHEDRAL CITY, Calif. & TORONTO–(BUSINESS WIRE)– EXPECTED TO ADD AN ADDITIONAL US$1MM PER MONTH IN REVENUE Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTC: AGEEF) is pleased to announce it has entered into a two-part agreement with Cannus Partners Inc. (“Cannus”) for procurement of biomass and supply bulk extract. Under the terms of […]

FSD Pharma’s Investments in Cutting-Edge Tech Could Pay Big Dividends

February 26th, 2019 - Ryan Allway

Many cannabis companies have predictable business models—they grow and sell cannabis flower or perhaps extract them into edibles or vape pens. While most companies are focused on maximizing their production footprint, some companies have placed an additional focus on research and development. These investments could pay big dividends in the future if they prove to […]

Aleafia Becomes First Cannabis Stock to Top TSX Venture 50 Performance Rankings

February 25th, 2019 - Ryan Allway

The TSX Venture exchange has become a popular place for cannabis companies to list their shares, particularly after Canada legalized recreational cannabis last year, but 2019 was the first year that a cannabis company topped its annual performance rankings. Aleafia Health Inc. (TSX-V: ALEF) (OTCQX: ALEAF) (FRA: ARAH), a vertically-integrated licensed producer with a clinic […]

Helix TCS, Inc. to Webcast Live at VirtualInvestorConferences.com February 20th

February 15th, 2019 - Ryan Allway

Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com DENVER, Feb. 15, 2019 /PRNewswire/ — Helix TCS, Inc. (OTCQB: HLIX), based in Denver, Colorado focused on critical infrastructure services to the legal cannabis industry, today announced that Zachary L. Venegas, Executive Chairman and CEO, will present […]

3 Sixty Risk Solutions Commences Trading on the Frankfurt Stock Exchange

February 15th, 2019 - Ryan Allway

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ ALMONTE, ON, Feb. 15, 2019 /CNW/ – 3 Sixty Risk Solutions Ltd. (“3 Sixty” or the “Company“) (CSE: SAFE) (FSE: 62P2), which operates through its wholly-owned subsidiary, 3 Sixty Secure Corp., is pleased to announce that it has commenced trading […]

Aleafia Health Announces new President of Clinic Operations

February 15th, 2019 - Ryan Allway

White to Lead Integration of Canabo Medical Clinics and GrowWise Health Post-closing of Emblem Acquisition Previously the COO of Canada’s Largest Multidisciplinary Clinic Network TORONTO, Feb. 15, 2019 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”), has named private healthcare executive Keith White as the Company’s […]


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading